RGCC International

01/06/2026

The Oncocount test is designed for patients diagnosed with cancer who wish to monitor the effectiveness of their ongoing treatment. It can also support early detection of recurrence for those in remission, helping patients and practitioners stay informed every step of the way.

🌱 Read more patient stories: rgcc-international.com/testimonials

27/05/2026

As Cancer Awareness Month comes to a close, it’s a great time to stay informed and take a closer look at the facts that matter. Learn more about skin , including its different types, stages, and available treatment options, in our patient guide.

📑Read it here: https://rgcc-international.com/patient-information/skin-cancer-treatment

-

Our experts explain the latest procedures for treating different skin cancer types and the role of new personalized approaches.

20/05/2026

How are healthcare practitioners using RGCC testing in clinical practice?

In this short clip, Dr. Neal Speight shares his experience using RGCC’s liquid biopsy and precision oncology tests to support more personalized cancer care and patient monitoring.

🎥 Watch the full interview on our YouTube channel to hear his complete insights and clinical perspective >> youtube.com/watch?v=vP7YkERV4g0

18/05/2026

RGCC’s Customer Relationship Manager, Gabriela Kranauer, participated in the “SSAAMP Jahreskongress 2026 – Universum Mensch und Gesundheit,” organized by the Swiss Society for Antiaging and Prevention and held in Zurich, Switzerland on May 16, 2026.

The congress brought together healthcare professionals and industry experts to discuss the latest developments in integrative and preventive medicine. Topics included longevity, long COVID, chronomedicine, and emerging supportive approaches in cancer care.

Events such as SSAAMP provide valuable opportunities to exchange knowledge, explore new scientific perspectives, and stay connected with ongoing advancements in healthcare and patient-centered care.

14/05/2026

We’re proud to showcase the certifications held by laboratories, reflecting our ongoing commitment to the highest standards of quality, safety, and reliability! From IAS Accreditation Testing to ISO certifications and recognitions from esteemed organizations like the College of American Pathologists and Swissmedic, our dedication to excellence is at the core of everything we do.

🏆 Check out the full details of our certifications on our website >> rgcc-international.com/

11/05/2026

Our dedicated scientific team is continuously uncovering new discoveries, delving into genetics, physiology, and different immune profiles.
🧫 Dive into our latest peer-reviewed research articles and abstracts to stay on top of the latest insights and discoveries: rgcc-international.com/published-articles/

07/05/2026

Our test provides a comprehensive overview of the Circulating Cells (CTCs) in a patient’s body by providing the following information:

🧬 A CTC count
🧬 A genetic and physiological expression profile of the cells
🧬 The effectiveness of 90+ chemotherapeutic agents and targeted therapies on the patient’s cancer cells
🧬 The resistance factor of the cancer cells

Learn more about the test >> rgcc-international.com/tests/onconomics/

04/05/2026

Using advanced molecular diagnostics and precision oncology testing, our diagnostics support personalized treatment decisions that move beyond a one-size-fits-all approach. By analyzing tumor-specific and genetic characteristics, our cancer tests enable clinicians to design individualized cancer treatment plans tailored to each patient’s unique disease profile.

🧪 Learn more: rgcc-international.com/tests/

01/05/2026

May is Skin Cancer Awareness Month.

Did you know? Ultraviolet (UV) radiation is a proven human carcinogen. The International Agency for Research on Cancer (IARC), part of the World Health Organization, classifies UV tanning devices as Group 1, meaning they are cancer-causing to humans, alongside risks such as to***co and solar UV radiation.

Protecting your and prioritizing early detection can make a real difference.

📈 Learn more about skin prevention, early detection, and treatment options: skincancer.org

-

28/04/2026

Cancer mortality can be significantly reduced when the disease is detected and treated early. Early detection relies on two key approaches: early diagnosis and screening.

For more insights and the latest information on , visit the World Health Organization (WHO) website: who.int/news-room/fact-sheets/detail/cancer